Global Biosimilar Testing Service Market Size, Status and Forecast 2024-2031

Report ID: 922961 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Pharmacokinetic Assay
        1.2.3 Tiered Immunogenicity Testing
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Biosimilar Testing Service Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Pharmaceutical Companies
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biosimilar Testing Service Market Perspective (2016-2027)
    2.2 Biosimilar Testing Service Growth Trends by Regions
        2.2.1 Biosimilar Testing Service Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biosimilar Testing Service Historic Market Share by Regions (2016-2021)
        2.2.3 Biosimilar Testing Service Forecasted Market Size by Regions (2022-2027)
    2.3 Biosimilar Testing Service Industry Dynamic
        2.3.1 Biosimilar Testing Service Market Trends
        2.3.2 Biosimilar Testing Service Market Drivers
        2.3.3 Biosimilar Testing Service Market Challenges
        2.3.4 Biosimilar Testing Service Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biosimilar Testing Service Players by Revenue
        3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2016-2021)
        3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2016-2021)
    3.2 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biosimilar Testing Service Revenue
    3.4 Global Biosimilar Testing Service Market Concentration Ratio
        3.4.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2020
    3.5 Biosimilar Testing Service Key Players Head office and Area Served
    3.6 Key Players Biosimilar Testing Service Product Solution and Service
    3.7 Date of Enter into Biosimilar Testing Service Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing Service Breakdown Data by Type
    4.1 Global Biosimilar Testing Service Historic Market Size by Type (2016-2021)
    4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2022-2027)

5 Biosimilar Testing Service Breakdown Data by Application
    5.1 Global Biosimilar Testing Service Historic Market Size by Application (2016-2021)
    5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biosimilar Testing Service Market Size (2016-2027)
    6.2 North America Biosimilar Testing Service Market Size by Type
        6.2.1 North America Biosimilar Testing Service Market Size by Type (2016-2021)
        6.2.2 North America Biosimilar Testing Service Market Size by Type (2022-2027)
        6.2.3 North America Biosimilar Testing Service Market Size by Type (2016-2027)
    6.3 North America Biosimilar Testing Service Market Size by Application
        6.3.1 North America Biosimilar Testing Service Market Size by Application (2016-2021)
        6.3.2 North America Biosimilar Testing Service Market Size by Application (2022-2027)
        6.3.3 North America Biosimilar Testing Service Market Size by Application (2016-2027)
    6.4 North America Biosimilar Testing Service Market Size by Country
        6.4.1 North America Biosimilar Testing Service Market Size by Country (2016-2021)
        6.4.2 North America Biosimilar Testing Service Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biosimilar Testing Service Market Size (2016-2027)
    7.2 Europe Biosimilar Testing Service Market Size by Type
        7.2.1 Europe Biosimilar Testing Service Market Size by Type (2016-2021)
        7.2.2 Europe Biosimilar Testing Service Market Size by Type (2022-2027)
        7.2.3 Europe Biosimilar Testing Service Market Size by Type (2016-2027)
    7.3 Europe Biosimilar Testing Service Market Size by Application
        7.3.1 Europe Biosimilar Testing Service Market Size by Application (2016-2021)
        7.3.2 Europe Biosimilar Testing Service Market Size by Application (2022-2027)
        7.3.3 Europe Biosimilar Testing Service Market Size by Application (2016-2027)
    7.4 Europe Biosimilar Testing Service Market Size by Country
        7.4.1 Europe Biosimilar Testing Service Market Size by Country (2016-2021)
        7.4.2 Europe Biosimilar Testing Service Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Testing Service Market Size (2016-2027)
    8.2 Asia-Pacific Biosimilar Testing Service Market Size by Type
        8.2.1 Asia-Pacific Biosimilar Testing Service Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biosimilar Testing Service Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biosimilar Testing Service Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biosimilar Testing Service Market Size by Application
        8.3.1 Asia-Pacific Biosimilar Testing Service Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biosimilar Testing Service Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biosimilar Testing Service Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biosimilar Testing Service Market Size by Region
        8.4.1 Asia-Pacific Biosimilar Testing Service Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biosimilar Testing Service Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biosimilar Testing Service Market Size (2016-2027)
    9.2 Latin America Biosimilar Testing Service Market Size by Type
        9.2.1 Latin America Biosimilar Testing Service Market Size by Type (2016-2021)
        9.2.2 Latin America Biosimilar Testing Service Market Size by Type (2022-2027)
        9.2.3 Latin America Biosimilar Testing Service Market Size by Type (2016-2027)
    9.3 Latin America Biosimilar Testing Service Market Size by Application
        9.3.1 Latin America Biosimilar Testing Service Market Size by Application (2016-2021)
        9.3.2 Latin America Biosimilar Testing Service Market Size by Application (2022-2027)
        9.3.3 Latin America Biosimilar Testing Service Market Size by Application (2016-2027)
    9.4 Latin America Biosimilar Testing Service Market Size by Country
        9.4.1 Latin America Biosimilar Testing Service Market Size by Country (2016-2021)
        9.4.2 Latin America Biosimilar Testing Service Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biosimilar Testing Service Market Size (2016-2027)
    10.2 Middle East & Africa Biosimilar Testing Service Market Size by Type
        10.2.1 Middle East & Africa Biosimilar Testing Service Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biosimilar Testing Service Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biosimilar Testing Service Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biosimilar Testing Service Market Size by Application
        10.3.1 Middle East & Africa Biosimilar Testing Service Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biosimilar Testing Service Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biosimilar Testing Service Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biosimilar Testing Service Market Size by Country
        10.4.1 Middle East & Africa Biosimilar Testing Service Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biosimilar Testing Service Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Charles River Laboratories International
        11.1.1 Charles River Laboratories International Company Details
        11.1.2 Charles River Laboratories International Business Overview
        11.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
        11.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2016-2021)
        11.1.5 Charles River Laboratories International Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Biosimilar Testing Service Introduction
        11.2.4 Merck Revenue in Biosimilar Testing Service Business (2016-2021)
        11.2.5 Merck Recent Development
    11.3 PPD
        11.3.1 PPD Company Details
        11.3.2 PPD Business Overview
        11.3.3 PPD Biosimilar Testing Service Introduction
        11.3.4 PPD Revenue in Biosimilar Testing Service Business (2016-2021)
        11.3.5 PPD Recent Development
    11.4 LAB Holdings
        11.4.1 LAB Holdings Company Details
        11.4.2 LAB Holdings Business Overview
        11.4.3 LAB Holdings Biosimilar Testing Service Introduction
        11.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2016-2021)
        11.4.5 LAB Holdings Recent Development
    11.5 Eurofins Scientific
        11.5.1 Eurofins Scientific Company Details
        11.5.2 Eurofins Scientific Business Overview
        11.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
        11.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2016-2021)
        11.5.5 Eurofins Scientific Recent Development
    11.6 Intertek
        11.6.1 Intertek Company Details
        11.6.2 Intertek Business Overview
        11.6.3 Intertek Biosimilar Testing Service Introduction
        11.6.4 Intertek Revenue in Biosimilar Testing Service Business (2016-2021)
        11.6.5 Intertek Recent Development
    11.7 SGS
        11.7.1 SGS Company Details
        11.7.2 SGS Business Overview
        11.7.3 SGS Biosimilar Testing Service Introduction
        11.7.4 SGS Revenue in Biosimilar Testing Service Business (2016-2021)
        11.7.5 SGS Recent Development
    11.8 Profacgen
        11.8.1 Profacgen Company Details
        11.8.2 Profacgen Business Overview
        11.8.3 Profacgen Biosimilar Testing Service Introduction
        11.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2016-2021)
        11.8.5 Profacgen Recent Development
    11.9 Antibody Analytics
        11.9.1 Antibody Analytics Company Details
        11.9.2 Antibody Analytics Business Overview
        11.9.3 Antibody Analytics Biosimilar Testing Service Introduction
        11.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2016-2021)
        11.9.5 Antibody Analytics Recent Development
    11.10 Kymos Pharma Services
        11.10.1 Kymos Pharma Services Company Details
        11.10.2 Kymos Pharma Services Business Overview
        11.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
        11.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2016-2021)
        11.10.5 Kymos Pharma Services Recent Development
    11.11 Medicilon
        11.11.1 Medicilon Company Details
        11.11.2 Medicilon Business Overview
        11.11.3 Medicilon Biosimilar Testing Service Introduction
        11.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2016-2021)
        11.11.5 Medicilon Recent Development
    11.12 Pacific BioLabs
        11.12.1 Pacific BioLabs Company Details
        11.12.2 Pacific BioLabs Business Overview
        11.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
        11.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2016-2021)
        11.12.5 Pacific BioLabs Recent Development
    11.13 Sartorius
        11.13.1 Sartorius Company Details
        11.13.2 Sartorius Business Overview
        11.13.3 Sartorius Biosimilar Testing Service Introduction
        11.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2016-2021)
        11.13.5 Sartorius Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Pharmacokinetic Assay
    Table 3. Key Players of Tiered Immunogenicity Testing
    Table 4. Key Players of Others
    Table 5. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Biosimilar Testing Service Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Biosimilar Testing Service Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Biosimilar Testing Service Market Share by Regions (2016-2021)
    Table 9. Global Biosimilar Testing Service Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Biosimilar Testing Service Market Share by Regions (2022-2027)
    Table 11. Biosimilar Testing Service Market Trends
    Table 12. Biosimilar Testing Service Market Drivers
    Table 13. Biosimilar Testing Service Market Challenges
    Table 14. Biosimilar Testing Service Market Restraints
    Table 15. Global Biosimilar Testing Service Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Biosimilar Testing Service Market Share by Players (2016-2021)
    Table 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing Service as of 2020)
    Table 18. Ranking of Global Top Biosimilar Testing Service Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Biosimilar Testing Service Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Biosimilar Testing Service Product Solution and Service
    Table 22. Date of Enter into Biosimilar Testing Service Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Biosimilar Testing Service Revenue Market Share by Type (2016-2021)
    Table 26. Global Biosimilar Testing Service Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Biosimilar Testing Service Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Biosimilar Testing Service Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Biosimilar Testing Service Revenue Market Share by Application (2016-2021)
    Table 30. Global Biosimilar Testing Service Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Biosimilar Testing Service Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Biosimilar Testing Service Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Biosimilar Testing Service Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Biosimilar Testing Service Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Biosimilar Testing Service Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Biosimilar Testing Service Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Biosimilar Testing Service Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Biosimilar Testing Service Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Biosimilar Testing Service Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Biosimilar Testing Service Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Biosimilar Testing Service Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Biosimilar Testing Service Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Biosimilar Testing Service Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Biosimilar Testing Service Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Biosimilar Testing Service Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Biosimilar Testing Service Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Biosimilar Testing Service Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Biosimilar Testing Service Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Biosimilar Testing Service Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Biosimilar Testing Service Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Biosimilar Testing Service Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Biosimilar Testing Service Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Biosimilar Testing Service Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Biosimilar Testing Service Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Biosimilar Testing Service Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Biosimilar Testing Service Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Biosimilar Testing Service Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Charles River Laboratories International Company Details
    Table 63. Charles River Laboratories International Business Overview
    Table 64. Charles River Laboratories International Biosimilar Testing Service Product
    Table 65. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 66. Charles River Laboratories International Recent Development
    Table 67. Merck Company Details
    Table 68. Merck Business Overview
    Table 69. Merck Biosimilar Testing Service Product
    Table 70. Merck Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. PPD Company Details
    Table 73. PPD Business Overview
    Table 74. PPD Biosimilar Testing Service Product
    Table 75. PPD Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 76. PPD Recent Development
    Table 77. LAB Holdings Company Details
    Table 78. LAB Holdings Business Overview
    Table 79. LAB Holdings Biosimilar Testing Service Product
    Table 80. LAB Holdings Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 81. LAB Holdings Recent Development
    Table 82. Eurofins Scientific Company Details
    Table 83. Eurofins Scientific Business Overview
    Table 84. Eurofins Scientific Biosimilar Testing Service Product
    Table 85. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 86. Eurofins Scientific Recent Development
    Table 87. Intertek Company Details
    Table 88. Intertek Business Overview
    Table 89. Intertek Biosimilar Testing Service Product
    Table 90. Intertek Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 91. Intertek Recent Development
    Table 92. SGS Company Details
    Table 93. SGS Business Overview
    Table 94. SGS Biosimilar Testing Service Product
    Table 95. SGS Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 96. SGS Recent Development
    Table 97. Profacgen Company Details
    Table 98. Profacgen Business Overview
    Table 99. Profacgen Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 100. Profacgen Recent Development
    Table 101. Antibody Analytics Company Details
    Table 102. Antibody Analytics Business Overview
    Table 103. Antibody Analytics Biosimilar Testing Service Product
    Table 104. Antibody Analytics Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 105. Antibody Analytics Recent Development
    Table 106. Kymos Pharma Services Company Details
    Table 107. Kymos Pharma Services Business Overview
    Table 108. Kymos Pharma Services Biosimilar Testing Service Product
    Table 109. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 110. Kymos Pharma Services Recent Development
    Table 111. Medicilon Company Details
    Table 112. Medicilon Business Overview
    Table 113. Medicilon Biosimilar Testing Service Product
    Table 114. Medicilon Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 115. Medicilon Recent Development
    Table 116. Pacific BioLabs Company Details
    Table 117. Pacific BioLabs Business Overview
    Table 118. Pacific BioLabs Biosimilar Testing Service Product
    Table 119. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 120. Pacific BioLabs Recent Development
    Table 121. Sartorius Company Details
    Table 122. Sartorius Business Overview
    Table 123. Sartorius Biosimilar Testing Service Product
    Table 124. Sartorius Revenue in Biosimilar Testing Service Business (2016-2021) & (US$ Million)
    Table 125. Sartorius Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosimilar Testing Service Market Share by Type: 2020 VS 2027
    Figure 2. Pharmacokinetic Assay Features
    Figure 3. Tiered Immunogenicity Testing Features
    Figure 4. Others Features
    Figure 5. Global Biosimilar Testing Service Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Pharmaceutical Companies Case Studies
    Figure 8. Others Case Studies
    Figure 9. Biosimilar Testing Service Report Years Considered
    Figure 10. Global Biosimilar Testing Service Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Biosimilar Testing Service Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Biosimilar Testing Service Market Share by Regions: 2020 VS 2027
    Figure 13. Global Biosimilar Testing Service Market Share by Regions (2022-2027)
    Figure 14. Global Biosimilar Testing Service Market Share by Players in 2020
    Figure 15. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing Service as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2020
    Figure 17. Global Biosimilar Testing Service Revenue Market Share by Type (2016-2021)
    Figure 18. Global Biosimilar Testing Service Revenue Market Share by Type (2022-2027)
    Figure 19. North America Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Biosimilar Testing Service Market Share by Type (2016-2027)
    Figure 21. North America Biosimilar Testing Service Market Share by Application (2016-2027)
    Figure 22. North America Biosimilar Testing Service Market Share by Country (2016-2027)
    Figure 23. United States Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Biosimilar Testing Service Market Share by Type (2016-2027)
    Figure 27. Europe Biosimilar Testing Service Market Share by Application (2016-2027)
    Figure 28. Europe Biosimilar Testing Service Market Share by Country (2016-2027)
    Figure 29. Germany Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Biosimilar Testing Service Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Biosimilar Testing Service Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Biosimilar Testing Service Market Share by Region (2016-2027)
    Figure 39. China Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Biosimilar Testing Service Market Share by Type (2016-2027)
    Figure 47. Latin America Biosimilar Testing Service Market Share by Application (2016-2027)
    Figure 48. Latin America Biosimilar Testing Service Market Share by Country (2016-2027)
    Figure 49. Mexico Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Biosimilar Testing Service Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Biosimilar Testing Service Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Biosimilar Testing Service Market Share by Country (2016-2027)
    Figure 55. Turkey Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Biosimilar Testing Service Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 59. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 60. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 61. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 62. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 63. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 64. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 65. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 66. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 67. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 68. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 69. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 70. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Charles River Laboratories International
Merck
PPD
LAB Holdings
Eurofins Scientific
Intertek
SGS
Profacgen
Antibody Analytics
Kymos Pharma Services
Medicilon
Pacific BioLabs
Sartorius
Frequently Asked Questions
Biosimilar Testing Service report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Testing Service report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Testing Service report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Imagery Analytics

Imagery analytics refers to collection of images or videos from the outer or inner surface of ear ... Read More